Skip to main content
. 2022 Jul 15;10(7):1713. doi: 10.3390/biomedicines10071713
meta <- metacont(N.HC, Mean.HC, SD.HC, N.MCI_AD,
Mean.MCI_AD, SD.MCI_AD, sm=“SMD”, data=data, studlab=paste(Author, Year))
 
## Warning in metacont(N.HC, Mean.HC, SD.HC, N.MCI_AD, Mean.MCI_AD, SD.MCI_AD, :
## Note, studies with non-positive values for n.e and / or n.c get no weight in
## meta-analysis.
 
meta$label.e <- “HC”
meta$label.c <- “MCI_AD”
print(meta, digits=2)
 
## SMD 95%-CI %W(fixed) %W(random)
## Bjerke 2009 -0.60 [-1.13; -0.08] 5.4 9.0
## Mattsson 2009 -1.17 [-1.34; -0.99] 47.3 19.2
## Hertze 2010 -0.85 [-1.29; -0.41] 7.8 11.0
## Palmqvist 2012 NA 0.0 0.0
## Spencer 2019 NA 0.0 0.0
## Hansson 2006 NA 0.0 0.0
## Hansson 2007 NA 0.0 0.0
## Hampel 2004 -1.92 [-2.77; -1.07] 2.1 4.6
## Herukka 2007 -1.31 [-1.77; -0.84] 6.8 10.3
## Lanari 2009 NA 0.0 0.0
## Papaliagkas 2009 NA 0.0 0.0
## Eckerstrom 2010 -1.81 [-2.48; -1.14] 3.3 6.5
## Kester 2011 NA 0.0 0.0
## Seppala 2011 -0.76 [-1.47; -0.06] 3.0 6.1
## Buchhave 2012 -1.15 [-1.57; -0.73] 8.5 11.5
## Parnetti 2012 NA 0.0 0.0
## Prestia 2013 NA 0.0 0.0
## Leuzy 2015 NA 0.0 0.0
## Baldeiras 2018 -1.36 [-1.74; -0.99] 10.6 12.8
## Khoonsari 2019 -0.72 [-1.26; -0.19] 5.2 8.8
## Santangelo 2020 NA 0.0 0.0
## Eckerstrom 2020 NA 0.0 0.0
## Brys 2009 NA 0.0 0.0
##
## Number of studies combined: k = 10
## Number of observations: o = 1758
##
## SMD 95%-CI z p-value
## Fixed effect model -1.14 [-1.26; -1.02] -18.35 < 0.0001
## Random effects model -1.13 [-1.33; -0.93] -10.88 < 0.0001
##
## Quantifying heterogeneity:
## tau^2 = 0.0481; tau = 0.2192; I^2 = 50.5% [0.0%; 76.0%]; H = 1.42
[1.00; 2.04]
##
## Test of heterogeneity:
## Q d.f. p-value
## 18.18 9 0.0331
##
## Details on meta-analytical method:
## - Inverse variance method
## - DerSimonian-Laird estimator for tau^2
## - Hedges’ g (bias corrected standardised mean difference)